Division Director
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
CAPT Monica Muñoz is the Director of the Division of Pharmacovigilance-I within US FDA’s Center for Drug Evaluation and Research. Since joining FDA in 2010, she has served as a safety reviewer, managed review teams, and provided oversight for pharmacovigilance initiatives. Her research interests have centered on better understanding postmarketing adverse event data, signal identification methodologies, and leveraging data science tools for surveillance. CAPT Muñoz also serves as a pharmacy officer in the US Public Health Service and has deployed for various missions, including in response to the Ebola epidemic in West Africa and most recently for COVID-19. She holds a PhD in Pharmacoepidemiology from the University of Florida and PharmD from Texas Tech University.